Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2006 Oct;55(10):1525-6.

Adverse events in clinical trials with azathioprine and mesalamine for prevention of postoperative recurrence of Crohn's disease

H Herfarth, C Tjaden, M Lukas, F Obermeier, K Dilger, R Müller, J Schölmerich; Z T-1 Study Group
Comment

Adverse events in clinical trials with azathioprine and mesalamine for prevention of postoperative recurrence of Crohn's disease

H Herfarth et al. Gut. 2006 Oct.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: None declared.

Comment on

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Ardizzone S, Maconi G, Sampietro G M.et al Azathioprine and mesalamine for prevention of relapse after conservative surgery for Crohn's disease. Gastroenterology 2004127730–740. - PubMed
    1. Hanauer S B, Korelitz B I, Rutgeerts P.et al Postoperative maintenance of Crohn's disease remission with 6‐mercaptopurine, mesalamine, or placebo: a 2‐year trial. Gastroenterology 2004127723–729. - PubMed
    1. Sandborn W J, Feagan B G. The efficacy of azathioprine and 6‐mercaptopurine for the prevention of postoperative recurrence in patients with Crohn's disease remains uncertain. Gastroenterology 2004127990–993. - PubMed

MeSH terms